Literature DB >> 27916646

Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology.

Ravikumar Manickam1, Walter Wahli2.   

Abstract

More than two decades of studying Peroxisome Proliferator-Activated Receptors (PPARs) has led to an understanding of their implications in various physiological processes that are key for health and disease. All three PPAR isotypes, PPARα, PPARβ/δ, and PPARγ, are activated by a variety of molecules, including fatty acids, eicosanoids and phospholipids, and regulate a spectrum of genes involved in development, lipid and carbohydrate metabolism, inflammation, and proliferation and differentiation of many cell types in different tissues. The hypolipidemic and antidiabetic functions of PPARα and PPARγ in response to fibrate and thiazolidinedione treatment, respectively, are well documented. However, until more recently the functions of PPARβ/δ were less well defined, but are now becoming more recognized in fatty acid metabolism, energy expenditure, and tissue repair. Skeletal muscle is an active metabolic organ with high plasticity for adaptive responses to varying conditions such as fasting or physical exercise. It is the major site of energy expenditure resulting from lipid and glucose catabolism. Here, we review the multifaceted roles of PPARβ/δ in skeletal muscle physiology.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27916646     DOI: 10.1016/j.biochi.2016.11.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  27 in total

1.  PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

Authors:  Xiangsheng Zuo; Yasunori Deguchi; Weiguo Xu; Yi Liu; Haiyan S Li; Daoyan Wei; Rui Tian; Weidong Chen; Min Xu; Yaying Yang; Shen Gao; Jonathan C Jaoude; Fuyao Liu; Sarah P Chrieki; Micheline J Moussalli; Mihai Gagea; Manu M Sebastian; Xiaofeng Zheng; Dongfeng Tan; Russell Broaddus; Jing Wang; Nadim J Ajami; Alton G Swennes; Stephanie S Watowich; Imad Shureiqi
Journal:  Gastroenterology       Date:  2019-03-15       Impact factor: 22.682

Review 2.  Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.

Authors:  Fatima Djouadi; Jean Bastin
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

3.  Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.

Authors:  Ryan M Van Wagoner; Amy Eichner; Shalender Bhasin; Patricia A Deuster; Daniel Eichner
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

4.  Acute binge alcohol alters whole body metabolism and the time-dependent expression of skeletal muscle-specific metabolic markers for multiple days in mice.

Authors:  Abigail L Tice; Joseph A Laudato; Debra A Fadool; Bradley S Gordon; Jennifer L Steiner
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-06       Impact factor: 5.900

5.  Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum-Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate.

Authors:  Bianca Seminotti; Morgana Brondani; Rafael Teixeira Ribeiro; Guilhian Leipnitz; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2022-05-31       Impact factor: 5.682

Review 6.  Research progress of signaling pathways of the natural substances intervene dyslipidemia (Review).

Authors:  Ningning Cao; Xiaoxuan Li; Wanjing Zhang; Qingguo Wang; Yujuan Liang; Fujun Zhou; Xuefeng Xiao
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 7.  NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging.

Authors:  Sabrina Wagner; Ravikumar Manickam; Marco Brotto; Srinivas M Tipparaju
Journal:  Mol Cell Biochem       Date:  2022-03-25       Impact factor: 3.396

8.  Transcriptomic analysis of chicken Myozenin 3 regulation reveals its potential role in cell proliferation.

Authors:  Maosen Ye; Fei Ye; Liutao He; Bin Luo; Fuling Yang; Can Cui; Xiaoling Zhao; Huadong Yin; Diyan Li; Hengyong Xu; Yan Wang; Qing Zhu
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

Review 9.  Targeting Energy Expenditure-Drugs for Obesity Treatment.

Authors:  Carlos M Jimenez-Munoz; Marta López; Fernando Albericio; Kamil Makowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 10.  Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Authors:  Eng Leng Saw; Swetha Ramachandran; Maria Valero-Muñoz; Flora Sam
Journal:  Curr Opin Cardiol       Date:  2021-03-01       Impact factor: 2.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.